This post was just published on ZYX Short Change Alert.
There are reports from England of issues with a promising drug trial for duchenne muscular dystrophy. If the rumors are true, the stock can easily fall to $30 to $37. Consider short selling up to 30% of the full core position size in the zone of $49.75 to $50.95, the stock is at $49.96. Stop zone is $51.31 to $51.85.
You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Check out our enviable performance in both bull and bear markets.
